Wim Robberecht

Wim Robberecht

Department of Neurosciences, KU Leuven - University of Leuven

Affiliated withKU Leuven - University of LeuvenVIBUniversity Hospitals Leuven

Research Area

Biography

Wim Robberecht has not added Biography.
If you are Wim Robberecht and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
<em>In Vivo</em> Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Publication title

Cited by 38

2018

Other Publications

Article
Year
Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery.

Expert opinion on investigational drugs| PubMed ID: 24816247

2014
2014
The role of oligodendroglial dysfunction in amyotrophic lateral sclerosis.

Neurodegenerative disease management| PubMed ID: 25095817

2014
2015
2015
2016
Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine| PubMed ID: 26940764

2016
2016
2016
2016
C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis.

Journal of neurology, neurosurgery, and psychiatry| PubMed ID: 27663272

2017
ATXN2 trinucleotide repeat length correlates with risk of ALS.

Neurobiology of aging| PubMed ID: 28017481

2017
2017
2017
Identification and characterization of Nanobodies targeting the EphA4 receptor.

The Journal of biological chemistry| PubMed ID: 28526745

2017
2017
Amyotrophic lateral sclerosis.

Nature reviews. Disease primers| PubMed ID: 28980624

2017
2018
Reconsidering the causality of TIA1 mutations in ALS.

Amyotrophic lateral sclerosis & frontotemporal degeneration| PubMed ID: 29235362

2018
2018
Elongator subunit 3 (ELP3) modifies ALS through tRNA modification.

Human molecular genetics| PubMed ID: 29415125

2018
2018
2018
2018